Occupational Stress
Conditions
Interventions
Experimental group: 50 women with moderate or high chronic stress will receive capsules containing Chinese herbal medicine (Gan Mai Da Zao) consisting of licorice (Glycyrrhizae uralensis), wheat (Seme
Dietary supplement
D20.215.784.500.350
HP3.073.433.101
Sponsors
Escola de Enfermagem da Universidade de São Paulo
Faculdade de Medicina da Universidade de São Paulo - FMUSP
Eligibility
Sex/Gender
Female
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Women in the morning or afternoon shift; aged 20 to 50 years; classified by the Vasconcellos Stress Symptom List (LSS) with medium or high stress of 37 to 119 points and sleep fully in the dark. Will be part of the research those who voluntarily want to participate, sign the informed consent and are available for data collection.
Exclusion criteria
Exclusion criteria: Those with gluten intolerance will be excluded, as one of the components of the GMDZ herbal medicine is wheat. Pregnant women will also be excluded; smokers; taking glucocorticoids in the last three months; HPA-influencing drugs such as beta-blockers, glucocorticoids, antidepressants, and psychoactive drugs; employees with less than one year of work at the institution, with vacations scheduled during the research period; who are on sick leave; make use of anxiolytics and antidepressants; those who use other complementary therapy (acupuncture, herbal medicine, reiki, flower therapy, among others). Those who were already using other allopathic medicines or who were already undergoing psychological therapy will not be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effectiveness of herbal medicine for reducing occupational stress, verified by comparing the phytotherapy and placebo groups of the salivary cortisol biomarker and the instrument scores. stress test for Lipp adults assessed before and after the intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in sleep quality, verified by urinary 6-sulfatoxymelatonin dosage and Pittsburgh Sleep Quality Index (PSQI) measured before and after interventions.;Improvement in anxiety and depression assessed by the HADS Hospital Anxiety and Depression Scale before and after the intervention. | — |
Countries
Brazil
Contacts
Public ContactGisele Kuba
Escola de Enfermagem da Universidade de São Paulo
Outcome results
None listed